Abstract
The prospects of neuro-enhancement have generated a large range of philosophical and ethical debates. The possibility of pediatric neuro-enhancement—using technology and pharmaceuticals to enhance children’s cognitive or emotive capacities—is particularly complicated for a number of reasons. One of the main reasons is that children (at least young children) are not autonomous and can therefore not possibly consent to any interventions. Nonetheless, parents can potentially make decisions to enhance the capacities of their children.
In this chapter I investigate ethical issues of pediatric neuro-enhancement and neuro-enhancement in elderly with diminishing autonomy. I argue that the similarities and differences between the philosophical and ethical questions that arise in the respective cases show how complicated neuro-enhancement in non-autonomous persons is. In particular, I look at three issues: (1) What kinds of autonomy are diminished or underdeveloped, and how does that affect the moral permissibility of neuro-enhancement? (2) What role does the concept of “an open future” play? (3) What does it mean to look out for “the best interest” of a child or a non-autonomous elderly person, and how does it translate to the permissibility of neuro-enhancement? I argue that the difference in how we conceptualize the non-autonomy of children and that of elderly affects the permissibility of neuro-enhancement. I conclude that, as long as we make sure that a person becomes autonomous enough to pursue her own autonomy as a condition and as an ideal, her best interests have been looked after in terms of autonomy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
Betzler (2015), arguing for the duty of parents to enhance their children’s “capacity for autonomy,” holds a similar position regarding what is to be enhanced. However, she takes a somewhat different approach, focusing on enhancing (while she is still a child) the child’s inherent ability to form virtues essential for autonomy (e.g., authenticity). This is an interesting angle on pediatric autonomy enhancement and is as far as I am concerned compatible with the approach I am putting forth in this chapter.
- 2.
In this paper I use dementia as an example of a condition that typically occurs in elderly populations and that diminishes a person’s autonomy.
- 3.
To be clear, I take it that these technologies are to be considered therapeutical and as such do not qualify as “enhancements.” This is of course debatable, as is the validity of the very distinction between therapy and enhancement itself. However, such matters cannot be discussed at length here.
- 4.
Note that the arguments at this point are to be read as depictions of lines of thought. As such, they are not airtight and do contain hidden premises, etc. For our purposes, however, they are sufficient.
- 5.
One may question some formulations regarding the normative permissibility of a given action in this example and examples on following pages (e.g., “it ought to be permissible”). The intention is to keep the arguments limited to statements that are normatively charged (ought) and that are made about hypothetical law and policy (permissible). Discussions about to what extent morally correct actions in general should be allowed according to law or policy, or what current legal and policy documents say about neuro-enhancement, can unfortunately not be had within the scope of this chapter.
- 6.
This could be an enhancement brought about by “overstimulation” using the treatment technology or by different means. The treatment that brings the elderly person back to an autonomous state is, at this point, not to be regarded as an enhancement.
- 7.
For a more elaborate discussion on authenticity and pediatric enhancement, see Betzler (2015).
References
Beauchamp T, Childress J (2013) Principles of biomedical ethics, 7th edn. Oxford University Press, Oxford
Betzler M (2015) Enhancing the capacity for autonomy: what parents owe their children to make their lives go well. In: Bagattini A, Macleod C (eds) The nature of children’s well-being. Springer, Amsterdam, pp 65–84
Bostrom N (2005) In defense of posthuman dignity. Bioethics 19(3):202–214
Christman JP (1989) The inner citadel: essays on individual autonomy. Oxford University Press, Oxford
Christman JP (ed) (2008) Autonomy in moral and political philosophy. Stanford encyclopedia of philosophy
Davis DS (1997) Genetic dilemmas and the child’s right to an open future. Hastings Cent Rep 27(2):7–15
Davis DS (2009) The parental investment factor and the child’s right to an open future. Hastings Cent Rep 39(2):24–27
Devadhasan JP, Kim S, An J (2011) Fish-on-a-chip: a sensitive detection microfluidic system for Alzheimer’s disease. J Biomed Sci 18(1):1
Ellis P (1996) Exploring the concept of acting in the patient’s best interests’. Br J Nurs 5(17):1072–1074
Feinberg J (1980) A child’s right to an open future. In: Aiken W, LaFollette H (eds) Whose child? Rowman and Littlefield, Totowa
Feinberg J (1988) Harm to self: the moral limits of the criminal law, vol 3. Oxford University Press, Oxford
Graf WD, Nagel SK, Epstein LG, Miller G, Nass R, Larriviere D (2013) Pediatric neuroenhancement ethical, legal, social, and neurodevelopmental implications. Neurology 80(13):1251–1260
Hsieh FY, Lin HH, Hsu SH (2015) 3D bioprinting of neural stem cell-laden thermoresponsive biodegradable polyurethane hydrogel and potential in central nervous system repair. Biomaterials 71:48–57
Mancuso J, Chen Y, Zhao Z, Li X, Xue Z, Wong ST (2013) Optogenetic stimulation of cholinergic projection neurons as an alternative for deep brain stimulation for Alzheimer’s treatment. In: SPIE BiOS. International Society for Optics and Photonics, p 85655M
Medina-Sánchez M, Miserere S, Morales-Narváez E, Merkoçi A (2014) On-chip magneto-immunoassay for Alzheimer’s biomarker electrochemical detection by using quantum dots as labels. Biosens Bioelectron 54:279–284
Nagel SK, Reiner PB (2013) Autonomy support to foster individuals’ flourishing. Am J Bioeth 13(6):36–37
Ross LF (1998) Children, families, and health care decision making. Oxford University Press, Oxford
Schaefer GO, Kahane G, Savulescu J (2014) Autonomy and enhancement. Neuroethics 7(2):123–136
Sheridan N (2013) Medical professionalism requires that the best interest of the patient must always come first. J Prim Health Care 5(1):74–75
Sjöstrand M, Eriksson S, Juth N, Helgesson G (2013) Paternalism in the name of autonomy. J Med Philos 38(6):710–724
Taylor JS (ed) (2005) Personal autonomy: new essays on personal autonomy and its role in contemporary moral philosophy. Cambridge University Press, Cambridge
Trau JM, McCartney JJ (1993) In the best interest of the patient. Health Prog 74:50–50
Zahedi A, Ethell I (2013) Optogenetics to regulate synaptic connectivity in Alzheimer’s disease. Alzheimers Dement 9(4):P703–P704
Zhu W, Castro NJ, Zhang LG (2015) Nanotechnology 3D bioprinting for neural tissue regeneration. In: Zhang LG, Fisher JP, Leong K (eds) 3D bioprinting and nanotechnology in tissue engineering and regenerative medicine. Academic Press, New York, pp 307–326
Acknowledgments
I would like to sincerely thank Saskia Nagel, Gregor Hörzer, the participants of the research week on pediatric neuro-enhancement in Osnabrück 2016, and two anonymous reviewers for extensive and deep feedback, discussions, and comments.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Lyreskog, D.M. (2019). Neuro-enhancement at the Margins of Autonomy: In the Best Interest of Children and Elderly?. In: Nagel, S. (eds) Shaping Children. Advances in Neuroethics. Springer, Cham. https://doi.org/10.1007/978-3-030-10677-5_4
Download citation
DOI: https://doi.org/10.1007/978-3-030-10677-5_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-10676-8
Online ISBN: 978-3-030-10677-5
eBook Packages: MedicineMedicine (R0)